Lv1
20 积分 2025-06-06 加入
IgA Nephropathy in Adults: A Review
19天前
已完结
Targeting the Pathogenesis of IgA Nephropathy - A New Treatment Approach?
19天前
已完结
Population Pharmacokinetics (PopPK) Support for Pediatric Dosing of Biological Products
26天前
已完结
Teclistamab in Multiple Myeloma with One to Three Previous Lines of Therapy
28天前
已完结
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
28天前
已完结
An evaluation of remission rates with first and second line treatments and indicators of antihistamine refractoriness in chronic urticaria
1个月前
已完结
Evaluation of Guideline Line-Care Approach to the Treatment of Chronic Inducible Urticaria
1个月前
已关闭
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
2个月前
已完结
Novel drug targets in 2025
2个月前
已完结
Acute promyelocytic leukemia: long-term outcomes from the HARMONY project
3个月前
已完结
皖公网安备34019202002308
